Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS
Clinical trial NCT05918978 · TERMINATED
Trial details
- NCT number
- NCT05918978
- Sponsor
- argenx
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2024-08-15
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.